Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(1973)Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid Am J Roentgenol Radium Ther Nucl Med 119 198-206

[3] Ferlay J(2013)Ovarian cancer: at the starting line Nat Rev Cancer 32 1775-1800

[4] Pisani P(2012)Ovarian carcinomatosis: how the radiologist can help plan the surgical approach Radiographics 5 219-228

[5] Meyers MA(2004)Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Lancet Oncol 12 765-777

[6] Seton-Rogers S(2005)Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions Ann Surg Oncol 20 38-54

[7] Nougaret S(2011)Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments Surg Oncol 221 29-42

[8] Addley HC(1995)Peritonectomy procedures Ann Surg 21 15-24

[9] Colombo PE(2009)Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer Curr Opin Obstet Gynecol 102 663-670

[10] Glehen O(2010)Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer J Surg Oncol 82 359-374

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108

[2] Bray F(1973)Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid Am J Roentgenol Radium Ther Nucl Med 119 198-206

[3] Ferlay J(2013)Ovarian cancer: at the starting line Nat Rev Cancer 32 1775-1800

[4] Pisani P(2012)Ovarian carcinomatosis: how the radiologist can help plan the surgical approach Radiographics 5 219-228

[5] Meyers MA(2004)Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Lancet Oncol 12 765-777

[6] Seton-Rogers S(2005)Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions Ann Surg Oncol 20 38-54

[7] Nougaret S(2011)Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments Surg Oncol 221 29-42

[8] Addley HC(1995)Peritonectomy procedures Ann Surg 21 15-24

[9] Colombo PE(2009)Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer Curr Opin Obstet Gynecol 102 663-670

[10] Glehen O(2010)Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer J Surg Oncol 82 359-374